VANC Pharmaceuticals, which focuses on the Canadian generic drug and over-the-counter (OTC) markets, has appointed Alan Arnstein to its Board of Directors.
Bob Rai, CEO, said: “I have worked with Alan for many years as he developed the Medicine Shoppe brand for the Katz Group of Companies.”
“Mr Arnstein's business relationships in the pharmacy will be an important asset as we build out VANC's product offerings to the Canadian pharmacy industry.”
Arnstein previously worked for the Katz Group Canada where he oversaw the development of the Medicine Shoppe from 28 stores to 175 stores (corporate and franchised) before the successful sale to McKesson Canada.
Arnstein also was involved in expanding the Rexall pharmacy brand across Canada, including responsibility for acquiring and consolidating independent pharmacies under the Rexall banner.
Arnstein has played and continues to play an active role in real estate projects including the leasing of the Ice District next to Rogers Place in downtown Edmonton.
David Hall, Chair of the Board, said: “This past year, we have embarked on a new programme to bring innovative and value-added products and services to pharmacies in Canada.”
“Alan's two decade executive experience with one of Canada's most successful pharmacy chains and his historical relationships in our industry will be invaluable to our growth.”
Arnstein said: “Pharmacists are hungry for new value added products and services that VANC is bringing to the market place and I am pleased to be part of this growing team.”
